Sofwave has received NMPA approval in mainland China, marking the company's entry into a market where skin-tightening demand is climbing alongside rising disposable income and aesthetic procedure adoption. The device combines ultrasound and radiofrequency microneedling to treat skin laxity and texture—a mechanism that works at 200 microns depth, shallower than traditional RF microneedling but sufficient for epidermal-to-dermal collagen remodeling without the downtime of ablative laser.
Devices & Tech
Sofwave Gets China Approval—New Market Entry
NMPA clearance opens mainland China for the ultrasound RF microneedling device.
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Sofwave enters mainland China with NMPA approval for RF microneedling.
The timing aligns with a broader trend: GLP-1 users globally are seeking body and facial skin tightening as weight loss outpaces skin elasticity recovery. Sofwave's clearance in China positions it to capture that segment in a market where medical aesthetics is moving from injectable-heavy to device-heavy service mixes. For U.S. practices, this signals that Sofwave's clinical data package is resonating with international regulators—a validation that may accelerate adoption among practitioners evaluating RF microneedling platforms.
Source: original report ↗
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.